Universal Ibogaine News
UNIVERSAL IBOGAINE ANNOUNCES CHIEF CLINICS OFFICER DR IAN RABB
Universal Ibogaine and PSQ are pleased to announce the completion of the Qualifying Transaction, closing the $6 million subscription receipt financing.
UNIVERSAL IBOGAINE ANNOUNCES ENGAGEMENT OF MEDIA AND INVESTOR RELTIONS ADVISORS
Universal Ibogaine and PSQ are pleased to announce the completion of the Qualifying Transaction, closing the $6 million subscription receipt financing.
UNIVERSAL IBOGAINE ANNOUNCES ENGAGEMENT OF INVESTOR RELTIONS ADVISOR
Universal Ibogaine and PSQ are pleased to announce the completion of the Qualifying Transaction, closing the $6 million subscription receipt financing.
UNIVERSAL IBOGAINE ANNOUNCES ENHANCEMENTS TO BOARD OF DIRECTORS
Universal Ibogaine and PSQ are pleased to announce the completion of the Qualifying Transaction, closing the $6 million subscription receipt financing.
UNIVERSAL IBOGAINE COMMENCES TRADING ON THE TSX-V
Universal Ibogaine and PSQ are pleased to announce the completion of the Qualifying Transaction, closing the $6 million subscription receipt financing.
Universal Ibogaine Announces Extension of Convertible Notes Payable and Engagement of Market Maker Firms
Universal Ibogaine and PSQ are pleased to announce the completion of the Qualifying Transaction, closing the $6 million subscription receipt financing.
OUR WHY
